DT
Deep Track Capital, LP disclosed a 5.5% stake in NRIX
Deep Track Capital, LP reported owning 5.5% of Nurix Therapeutics, Inc. (NRIX) (6,000,000 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G